Liver Adiposity Effects on Pediatric Statin

Cholesterol; Lipidosis Clinical Trial

Official title:
Effects of Pediatric Liver Adiposity on Statin Disposition and Response

Status Recruiting

Clinical Trial Summary

Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cholesterol; Lipidosis

Clinical Trial Details

NCT number	NCT04903223
Study type	Interventional
Source	Children's Mercy Hospital Kansas City
Contact	Jonathan Wagner, DO
Phone	816-731-7240
Email	jbwagner@cmh.edu
Status	Recruiting
Phase	Phase 1
Start date	April 1, 2021
Completion date	January 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03542370` - Umbrella Review of the DASH Dietary Pattern and Cardiometabolic Risk
Recruiting	`NCT04833595` - Can Mindful Eating Improve Cholesterol and Glucose Level	N/A
Completed	`NCT04373863` - Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population
Completed	`NCT05093803` - Improvement of Physical and Physiological Parameters Through the Use of a Mobile App	N/A
Active, not recruiting	`NCT03534414` - Meta-analysis of the Portfolio Dietary Pattern and Cardiometabolic Risk
Completed	`NCT05628259` - The Effect of Tele-Nursing Based Motivational Interviewing in Individuals With Type 2 Diabetes:RCT	N/A